And with that increasing complexity come rising costs and the risk of delays that can slow the delivery of critical medicines to patients awaiting treatments – and flatten drug sponsors’ return on ...

Clinical development accelerator Quotient Sciences and CRO Lindus Health are joining forces to create a streamlined process for clients to advance from first-in-human (FIH) up to pivotal trials.

Swinerton Incorporated (Swinerton) announces Executive Vice President and Chief Revenue Officer (CRO) Don Adair will retire ...

Alira Health, a global advisory firm and CRO, today announced the appointment of Dr. Susanne Schaffert as Senior Advisor and Patient-Centric Ambassador. Dr. Schaffert is a highly respected ...

Bantam Pharmaceutical, a clinical-stage company pioneering mitochondrial biology to develop first-in-class medicines for ...

Rain-soaked fields, stubborn fungal diseases, and tightening residue rules are converging in the world’s top banana-exporting ...

Outseer, a global leader in all-cause digital fraud prevention for financial institutions, today announced the appointment of Shane Cumming as Chief Revenue Officer (CRO). With more than two decades ...

Lindus Health and Quotient Sciences partner to speed up drug development from first-in-human to pivotal trials: Boston Wednesday, December 17, 2025, 17:00 Hrs [IST] Lindus Health, ...

Leadgene Biosolutions, Inc. (formerly CYTENA BPS), following its transition out of the BICO Group, now officially integrates with Leadgene Biomedical, a biotechnology ...

Kytes is Helping Enterprises Achieve 10x Growth with Purpose-Built Project Management SoftwareMaharashtra, India, December 17 ...

GreensKeeper Asset Management, an investment management company, released its third-quarter 2025 investor letter. A copy of ...

SHOPLINE, the global commerce platform trusted by over 600,000 merchants, today announced a new partnership with Hive Analytics, a performance marketing and growth strategy agency that builds ...